Clinical Trials Logo

Filter by:
NCT ID: NCT02939599 Terminated - Clinical trials for Pulmonary Arterial Hypertension

Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients

Start date: February 1, 2018
Phase: Phase 2
Study type: Interventional

This is a long-term open-label safety extension to the Phase 2a study of inhaled QCC374 in adult patients with PAH. This study provides the patients who completed the QCC374X2201 study with the option to continue receiving QCC374. The study will monitor the long-term safety, tolerability and efficacy of QCC374 in patients with PAH.

NCT ID: NCT02938078 Terminated - Blepharitis Clinical Trials

Ocular Comfort and Inflammation in Lid Hygiene Therapy

Start date: October 2016
Phase: N/A
Study type: Interventional

The primary study objectives are: to evaluate (1) the change in ocular discomfort at 30 days and (2) the change in signs and symptoms of ocular surface disease in demodex-positive subjects beginning the use of Avenova.

NCT ID: NCT02937766 Terminated - Clinical trials for Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women

Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

Start date: October 7, 2016
Phase: Phase 3
Study type: Interventional

To demonstrate that Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) delivered subcutaneously via auto-injector is associated with less pain as compared to intramuscular injections of Makena®

NCT ID: NCT02937675 Terminated - Lymphoma Clinical Trials

A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies

Start date: February 8, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This clinical trial is a Phase 1-2, open-label, sequential-group, dose-escalation and cohort-expansion study evaluating the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of Tomivosertib (eFT-508). The study will evaluate oral daily administration of Tomivosertib (eFT-508). Treatment and study subject evaluation will be performed in 21-day cycles.

NCT ID: NCT02937402 Terminated - Clinical trials for Small Cell Lung Carcinoma

Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer

Start date: April 5, 2018
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well bronchoscopy with bronchoalveolar lavage works in identifying biomarkers of response to immune checkpoint inhibitors in patients with non-small cell or small cell lung cancer. Bronchoscopy uses a thin, tube-like instrument inserted through the nose or mouth to view the inside of the trachea, air passages, and lungs. Bronchoalveolar lavage washes out the bronchi and alveoli by flushing with a fluid. Bronchoscopy with bronchoalveolar lavage may make it easier to help determine biomarkers that are more present in some cancers than others that will help determine which individuals have a greater or lesser chance of benefiting from immunotherapy.

NCT ID: NCT02937168 Terminated - Asthma Clinical Trials

An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation

DEAR
Start date: May 8, 2017
Phase: Phase 4
Study type: Interventional

This is an exploratory study with the following primary objectives: 1) to establish that PET/CT of the lung can reliably distinguish healthy, non-asthmatic participants from participants with severe asthma and an eosinophilic phenotype and 2) to examine the utility of PET/CT for demonstrating that reslizumab produces a reduction in lung inflammation in participants with severe asthma and an eosinophilic phenotype .

NCT ID: NCT02937038 Terminated - Dehydration Clinical Trials

Reference Values and Determinants of Hydration in Children 3-13 y

HYBISKUS
Start date: June 2016
Phase:
Study type: Observational

Purpose: 1. Develop reference values for hydration biomarkers for children of 3 to 13 years old 2. Explore the association between children's and parents' hydration markers and fluid intake habits in children aged 3-13 y 3. Evaluate the equivalence of spot urine osmolality to 24h urine osmolality in children aged 3-13 y 4. Evaluate the differences in hydration markers between school and non-school days in children aged 3-13 y 5. Examine the role of different foods and fluids on hydration in children (3-13 y) and parents

NCT ID: NCT02936999 Terminated - Breast Cancer Clinical Trials

Vitamin D Supplementation in Women With DCIS and/or LCIS

Start date: August 2016
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to determine the safety and usefulness of oral Vitamin D supplementation in subjects with in situ carcinoma. More specifically, this study is being done to (1) understand the effect of Vitamin D supplementation on behavior of breast cancer cells and (2) the development of invasive breast cancer disease.

NCT ID: NCT02936206 Terminated - Breast Cancer Clinical Trials

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Start date: October 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to microscopically examine breast cancer cells of pre-menopausal and post-menopausal women before and after exposure to one of the two commonly used breast cancer drugs, tamoxifen or fulvestrant.

NCT ID: NCT02936128 Terminated - Clinical trials for Chronic Venous Leg Ulcers

TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers

Start date: July 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic venous leg ulcers.